News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
208,796 Results
Type
Article (19269)
Company Profile (37)
Press Release (189490)
Section
Business (56730)
Career Advice (443)
Deals (8465)
Drug Delivery (28)
Drug Development (25964)
Employer Resources (33)
FDA (4467)
Job Trends (5000)
News (94983)
Policy (7561)
Tag
Academia (1876)
Alliances (17171)
Alzheimer's disease (578)
Approvals (4496)
Artificial intelligence (89)
Bankruptcy (66)
Best Places to Work (4181)
Breast cancer (110)
Cancer (821)
Cardiovascular disease (56)
Career advice (390)
CAR-T (51)
Cell therapy (158)
Clinical research (20489)
Collaboration (321)
Compensation (122)
COVID-19 (1215)
C-suite (68)
Data (779)
Diabetes (56)
Diagnostics (2511)
Earnings (16006)
Events (29306)
Executive appointments (224)
FDA (4864)
Funding (305)
Gene therapy (117)
GLP-1 (152)
Government (1419)
Healthcare (6449)
Infectious disease (1261)
Interviews (54)
IPO (4020)
Job creations (1132)
Job search strategy (353)
Layoffs (114)
Legal (1326)
Lung cancer (129)
Lymphoma (57)
Manufacturing (76)
Medical device (4137)
Medtech (4137)
Mergers & acquisitions (4645)
Metabolic disorders (122)
Neuroscience (731)
NextGen: Class of 2025 (2250)
Non-profit (2096)
Northern California (918)
Obesity (54)
Opinion (71)
Patents (48)
People (19757)
Phase I (6873)
Phase II (9399)
Phase III (6494)
Pipeline (303)
Postmarket research (679)
Preclinical (3008)
Radiopharmaceuticals (97)
Rare diseases (137)
Real estate (1825)
Regulatory (5441)
Research institute (1956)
Resumes & cover letters (47)
Series A (50)
Southern California (858)
Startups (1456)
United States (8053)
Vaccines (258)
Date
Today (1)
Last 7 days (274)
Last 30 days (1232)
Last 365 days (15194)
2025 (2055)
2024 (15137)
2023 (13497)
2022 (16686)
2021 (17835)
2020 (16972)
2019 (14831)
2018 (11090)
2017 (11659)
2016 (10737)
2015 (11869)
2014 (8573)
2013 (7039)
2012 (7230)
2011 (7490)
2010 (6575)
Location
Africa (292)
Arizona (51)
Asia (13739)
Australia (2758)
California (2099)
Canada (656)
China (126)
Colorado (113)
Connecticut (133)
Delaware (69)
Europe (27007)
Florida (318)
Georgia (89)
Illinois (207)
Indiana (100)
Japan (63)
Maryland (277)
Massachusetts (1669)
Michigan (67)
Minnesota (117)
New Jersey (684)
New York (552)
North Carolina (260)
Northern California (918)
Ohio (73)
Pennsylvania (499)
South America (389)
Southern California (858)
Texas (337)
Utah (55)
Washington State (204)
208,796 Results for "biomed x institute".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
BioMed X Launches New US Institute in New Haven, CT
Connecticut Governor Ned Lamont, New Haven Mayor Justin Elicker, and Josh Geballe, Managing Director of Yale Ventures, participated in the launch ceremony of the new BioMed X Institute on Tuesday, June 11, 2024.
June 13, 2024
·
3 min read
Biotech Bay
BioMed X Institute and Boehringer Ingelheim Successfully Complete Schizophrenia Research Project
German independent research institute BioMed X announces the successful completion of its second neuroscience project in partnership with Boehringer Ingelheim in the field of psychiatric disorders.
May 28, 2024
·
3 min read
Drug Development
BioMed X Start Collaboration in Autoimmunity Research with Servier
The new research team at the BioMed X Institute in Heidelberg will develop a novel strategy to selectively target autoreactive plasma cells in autoimmune disease.
June 26, 2024
·
3 min read
Job Trends
New Immuno-Oncology Research Project in Partnership With Merck Starts at the BioMed X Institute in Heidelberg
BioMed X, a German biomedical research institute, announces the start of a new research project in partnership with Merck at its site in Heidelberg, Germany.
April 30, 2024
·
2 min read
Business
BioMed X Institute and Ono Pharmaceutical Launch New Collaboration in Cancer Research
BioMed X announced a new joint research project with Ono Pharmaceutical Co., Ltd, marking the start of the collaboration between the German biomedical research institute and one of the largest pharmaceutical companies in Japan.
December 19, 2023
·
3 min read
Business
BioMed X and AbbVie Start New Research Project in the USA
BioMed X, an independent biomedical research institute, announces the start of a research project in collaboration with AbbVie to be hosted by the new BioMed X Institute in New Haven, CT, USA.
October 31, 2023
·
3 min read
BioMed X Launches a New Call for Application in Autoimmune Disease Research
BioMed X, an independent biomedical research institute, announced yesterday the launch of a Call for Application in immunology.
November 7, 2023
·
2 min read
Press Releases
Orchestra BioMed to Present at Upcoming Investor Conferences
February 20, 2025
·
2 min read
Call for Application to Researchers for Joint Research Project between Ono Pharmaceutical and BioMed X
Ono Pharmaceutical Co., Ltd. informed that it has started a new collaboration with BioMed X on cancer immunotherapies and has been inviting researchers who are interested in this research project via BioMed X.
January 9, 2024
·
1 min read
SNIPR Biome receives funding from CARB-X to support advancement of CRISPR-medicine SNIPR001 into clinical trials in haematological cancer patients
SNIPR Biome ApS (“SNIPR”) announces today that it has received $5.48 million from Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (“CARB-X”) to co-fund a Phase 1b/2a clinical trial in hematological cancer patients.
April 22, 2024
·
6 min read
1 of 20,880
Next
